/Companies

Nexcida Therapeutics

Menlo Park, US · Founded 2014 · Delaware corporation · 4 known investors

Find your way into Nexcida Therapeutics

Sign up to see every warm intro you have to Nexcida Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nexcida Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DS
David SocksNamed on SEC filing

Board

YG
Yigong GeBoard director
CY
Chen YuBoard directorDirector at Vivo Capital
PHPatrick Heron
Patrick HeronBoard directorManaging Partner at Frazier Life Sciences
BA
Brent AhrensBoard director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$2.8M disclosed across 1 round · 2015

▶$2.8MraisedJun 2015 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Yigong GeDirector
  • Chen YuDirector
  • Patrick HeronDirector
  • Brent AhrensDirector
  • David SocksExecutive Officer, Director, Promoter
Offering amount
$21.3M
Amount sold
$2.8M
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Nexcida Therapeutics's investors?
Nexcida Therapeutics's investors include Canaan Partners, Frazier, Frazier Life Sciences, Vivo Capital.
How much funding has Nexcida Therapeutics raised?
Nexcida Therapeutics has disclosed $2.8M raised across 1 round.
Where is Nexcida Therapeutics headquartered?
Nexcida Therapeutics is headquartered in Menlo Park, US.